ABT-046
ABT-046 is a potent and selective oral DGAT-1 inhibitor used in metabolic disease research. It has been employed in studies investigating obesity and type 2 diabetes, demonstrating utility in both in vitro enzymatic assays and in vivo models of metabolic dysfunction.
Product Specifications
CAS Number
1031336-60-3
Product Name Alternative
ABT 046, ABT046, ABT-046
Field of Research
Metabolism Research
Purity
98.13% (May vary between batches)
Solubility
DMSO:50 mg/mL (142.69 mM)
Smiles
NC1=C (C=NC=2N1N=CC2) C3=CC=C (C=C3) [C@@H]4CC[C@@H] (CC (O) =O) CC4
Molecular Formula
C20H22N4O2
Molecular Weight
350.41
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6384199-01 0.1 mL
LILRA3 (ILT6, CD85e, Leukocyte Immunoglobulin-like Receptor Subfamily A Member 3, CD85 Antigen-like Family Member E, Immunoglobulin-like Transcript 6, ILT-6, Leukocyte Immunoglobulin-like Receptor 4, LIR-4, Monocyte Inhibitory Receptor HM43/HM31, LIR4) (M
Sign In for Pricing
View Details MBS6384199-02 5x 0.1 mL
LILRA3 (ILT6, CD85e, Leukocyte Immunoglobulin-like Receptor Subfamily A Member 3, CD85 Antigen-like Family Member E, Immunoglobulin-like Transcript 6, ILT-6, Leukocyte Immunoglobulin-like Receptor 4, LIR-4, Monocyte Inhibitory Receptor HM43/HM31, LIR4) (M
Sign In for Pricing
View Details 
MBS6454573-01 0.1 mL
C15orf2 (Nuclear pore-Associated Protein 1, NPAP1, C15orf2) (MaxLight 490)
Sign In for Pricing
View Details MBS6454573-02 5x 0.1 mL
C15orf2 (Nuclear pore-Associated Protein 1, NPAP1, C15orf2) (MaxLight 490)
Sign In for Pricing
View Details